Profil
Fang Ni worked as the Director of Global Business Development & Licensing at F.
Hoffmann-La Roche Ltd. from 2013 to 2017.
From 2017 to 2020, Dr. Ni was a Principal at Versant Ventures (Switzerland) GmbH.
Dr. Ni then held the position of Chief Business Officer at Monte Rosa Therapeutics AG and Bright Peak Therapeutics AG.
Currently, Dr. Ni is the Chief Financial & Business Officer at Black Diamond Therapeutics, Inc. Dr. Ni obtained a doctorate degree from Purdue University.
Ehemalige bekannte Positionen von Fang Ni
| Unternehmen | Position | Ende |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Finanzdirektor/CFO | 07.10.2024 |
Versant Ventures (Switzerland) GmbH
Versant Ventures (Switzerland) GmbH Investment ManagersFinance Acts as an alternative investment manager | Private-Equity-Analyst | 01.08.2020 |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01.11.2017 |
Bright Peak Therapeutics AG
Bright Peak Therapeutics AG BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Corporate Officer/Principal | - |
Monte Rosa Therapeutics AG
Monte Rosa Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes cancer drugs that modulates protein degradation pathways | Corporate Officer/Principal | - |
Ausbildung von Fang Ni
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Purdue University
Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versant Ventures (Switzerland) GmbH
Versant Ventures (Switzerland) GmbH Investment ManagersFinance Acts as an alternative investment manager | Finance |
Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops precision medicines for cancer | Health Technology |
Monte Rosa Therapeutics AG
Monte Rosa Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes cancer drugs that modulates protein degradation pathways | Health Technology |
Bright Peak Therapeutics AG
Bright Peak Therapeutics AG BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Health Technology |
















